Nominated for The Scientists’ Choice Award for Best New Life Sciences Product of the Year, DeNovix Inc. will be exhibiting the DS-11 FX+ Spectrophotometer / Fluorometer with Enhanced Lower Detection Limit at AACR 2016.
DeNovix Inc., a developer and manufacturer of life science instrumentation and assays will showcase the DS-11 FX+ Spectrophotometer / Fluorometer at this year’s American Association of Cancer Research (AACR 2016) meeting in New Orleans, LA.
Image credit: DeNovix
The DeNovix DS-11 FX+ combines patent pending absorbance and fluorescence technologies to deliver the most flexible and complete system available for nucleic acid and protein quantification. DeNovix SmartPath® Technology enables rapid and accurate 1µL UV-Vis quantification over an industry-leading dynamic range. The addition of fluorescence also enables researchers to measure picogram concentrations of sample with increased specificity in one compact instrument.
“Fundamental questions in research are now being asked of single or rare cells and their role in developmental processes or disease progression.” said Fred Kielhorn, CEO of DeNovix. “With the development of our DS-11 FX Series Spectrophotometer / Fluorometer and the integration of our Ultra High Sensitivity fluorescence assays, researchers now have the tools to combine the advantages of both absorbance and fluorescence methods to rapidly determine quantity and quality of routine and challenging samples”.
The DS-11 FX Series features full Wi-Fi, USB, and Ethernet connectivity allowing users to easily export data via email, a USB drive, to network drives or Wi-Fi printers, or print cryotube labels with an optional printer. Measurements are made using DeNovix’s highly rated, custom Android™ operating system and a stunning, high-resolution, glove-compatible touch screen. Intuitive EasyApps® software featuring pre-configured and custom applications make the DS-11 Series easy to use but powerful and flexible.